Advinus Therapeutics Ltd., the TATA promoted Pharmaceutical R&D Co., has received a $3 million milestone for the first successful year in its R&D collaboration with Takeda Pharmaceutical Co.
In October 2012, the companies entered a multi-year, multi-project drug discovery collaboration. Advinus is responsible for carrying out all research required to identify candidate molecules for clinical development in several therapeutic areas, and Takeda is responsible for development and commercialization.
"Achievement of the rather challenging first year milestone can be attributed to the truly collaborative nature of our relationship with Takeda as well as Advinus' ability to solve complex problems with efficiency and speed,” said Kasim Mookhtiar, chief scientific officer of Advinus.
Advinus Earns Takeda Milestone
By Kristin Brooks
Published January 7, 2014
blog comments powered by Disqus